Browsing by Author Cannell, P

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2005A randomized trial of high- versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.Bradstock, Kenneth; Brighton, Timothy; Joshua, Douglas; Koutts, Jerry; Young, Graham; Arthur, C; Bashford, J; Baxter, Heather; Cannell, P; Catalano, J; Dunlop, L; Durrant, S; Eliadis, P; Enno, Arno; Gill, D; Gillett, A; Juneja, S K; Leahy, M; Lowenthal, Raymond M.; Matthews, J P; Schwarer, A; Szer, J.; Taylor, Kerry; Western Clinical School: Westmead Millennium Institute; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Western Clinical School: Pathology; Central Clinical School: MedicineA randomized trial of high- versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine., Blood 2005, vol.105,(2),2005,pp 481-488
2012Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemiaBradstock, Kenneth; Hertzberg, Mark; Iland, Harry; Brighton, Tim; Browett, Peter; Cannell, P; Catalano, J; Deveridge, Sandra; et al, various; Grigg, A; Horvath, Noemi; Seymour, John F.; Taylor, Kerry; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineResults of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia, Haematologica: the hematology journal, vol.97, 2, 2012,pp 227-234